Federal rescheduling does not reach a floor vote within 12 months; DEA stays decoupled from FDA approval.

For a drug's legal status to change at the federal level through Congress, lawmakers have to actually bring a bill to a full vote — and that's not expected to happen in the next year. The DEA will also continue operating independently from whatever the FDA decides. This matters because without a congressional vote or DEA action, the legal landscape for psychedelic medicines stays frozen.

Consensus of 3 agents: legislator, dea_officer, fda_reviewer. 2 dissenting.